Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Clarita V, Odvina"'
Autor:
Charles Y C, Pak, Khashayar, Sakhaee, Orson W, Moe, John, Poindexter, Beverley, Adams-Huet, Margaret S, Pearle, Joseph E, Zerwekh, Glenn M, Preminger, Michael R, Wills, Neil A, Breslau, Fredric C, Bartter, D C, Brater, Howard J, Heller, Clarita V, Odvina, Cindy L, Wabner, John S, Fordtran, Man, Oh, Abhimanyu, Garg, Jean A, Harvey, Robert J, Alpern, William H, Snyder, Paul C, Peters
Publikováno v:
Kidney International. 80:777-782
The classic definition of hypercalciuria, an upper normal limit of 200 mg/day, is based on a constant diet restricted in calcium, sodium, and animal protein; however, random diet data challenge this. Here our retrospective study determined the validi
Publikováno v:
Clinical Endocrinology. 72:161-168
Summary Background Bisphosphonates are the most commonly prescribed medications for the treatment of osteoporosis. Although existing evidence supports a good safety profile, there is concern that chronic administration of these agents could result in
Autor:
Howard J. Heller, Clarita V. Odvina, Charles Y.C. Pak, Roy D. Peterson, John R. Poindexter, Paulette Padalino, Khashayar Sakhaee
Publikováno v:
Urological Research. 35:123-128
The exact metabolic-physiological background for kidney stone formation in primary hyperparathyroidism (PHPT) is unclear. To obtain clarification, this retrospective data analysis was conducted in 131 patients with PHPT who had undergone a detailed a
Autor:
Charles Y.C. Pak, Clarita V. Odvina
Publikováno v:
The Endocrinologist. 16:150-154
This update reviews salient progress in pathophysiology, diagnosis, and medical management. In absorptive hypercalciuria, bone loss accompanies stone formation in some patients. Potential putative gene (soluble adenylyl cyclase) has been identified.
Autor:
Clarita V. Odvina
Publikováno v:
Journal of Investigative Medicine. 54:114-122
Osteoporosis develops as a result of imbalance between bone resorption and bone formation. A number of effective and safe therapies for osteoporosis are currently available, most of which are inhibitors of bone resorption. However, because osteoporos
Publikováno v:
American Journal of Therapeutics. 13:101-108
Thiazide can cause magnesium depletion, which may exaggerate renal potassium wasting and hypokalemia. The purpose of this double-blind, randomized trial was to compare the metabolic effects of potassium-magnesium-citrate (K-Mg-citrate) and potassium
Publikováno v:
Endocrine Practice. 12:48-53
To report 3 cases of bisphosphonate-induced hypocalcemia and review the relevant literature.We present the clinical and laboratory findings in 3 cases of bisphosphonate-induced hypocalcemia, and discuss the pathophysiologic mechanisms and the pertine
Autor:
Clarita V. Odvina, Linda J. Brinkley, Khashayar Sakhaee, Charles Y.C. Pak, Margaret S. Pearle, Roy D. Peterson, John R. Poindexter
Publikováno v:
Kidney International. 68:2264-2273
Effect of dietary modification on urinary stone risk factors.BackgroundThis study was undertaken to ascertain the effect of dietary modification on urinary stone risks, and to determine whether the response depends on the prevailing urinary calcium.M
Autor:
Charles Y.C. Pak, Clarita V. Odvina, Margaret S. Pearle, Howard J. Heller, Roy D. Peterson, John R. Poindexter
Publikováno v:
The Journal of Urology. :465-469
Purpose: We determined whether dietary restriction of calcium and oxalate, combined with thiazide and potassium citrate treatment, would prevent stone formation and avert bone loss in 18 men and 10 women with type I absorptive hypercalciuria.Material
Publikováno v:
Kidney International. 63:240-247
Long-term combined treatment with thiazide and potassium citrate in nephrolithiasis does not lead to hypokalemia or hypochloremic metabolic alkalosis. Background Potassium citrate is commonly used in combination with a thiazide diuretic in the medica